Researchers have developed a simplified DNA extraction method to streamline the diagnostic process for Kaposi’s sarcoma (KS) (1). We spoke with corresponding author David Erickson to learn more.
Why focus on the KS diagnostic workflow?
The study was inspired by the need for faster, more accessible diagnostic methods for KS – particularly in regions with limited access to centralized laboratories. Previous work showed that extracting DNA from skin biopsies was the bottleneck in point-of-care (POC) diagnostics using loop-mediated isothermal amplification (LAMP). This research aimed to develop a simpler, equipment-free DNA extraction method to streamline the process, ultimately enabling quicker and more effective KS diagnosis in low-resource settings.
What is ColdSHOT?
ColdSHOT is a simplified, ambient-temperature DNA extraction method using sodium hydroxide (NaOH) to lyse cells without the need for heating or mechanical homogenization.
Traditional methods like spin column extractions involve more steps, such as tissue digestion, multiple buffer washes, and centrifugation, which require equipment and are time-intensive. In contrast, ColdSHOT uses a basic NaOH solution followed by neutralization, allowing for DNA extraction from small tissue samples without significant equipment.
How does ColdSHOT, without significant equipment, manage to achieve comparable DNA yields to spin column extractions?
ColdSHOT achieves comparable DNA yields by leveraging the high alkalinity of NaOH, which effectively breaks down cellular and nuclear membranes to release DNA. While it lacks the purification steps of spin columns, the NaOH lysis in ColdSHOT provides enough disruption to extract DNA from submillimeter tissue samples. Although it does not fully homogenize the tissue, it extracts sufficient DNA for the LAMP-based detection of targets like the KSHV, making it suitable for use at the POC.
What challenges did you encounter during your research – and how did you overcome them?
One challenge was achieving consistent DNA yields without using heat, which is traditionally employed to accelerate alkaline DNA extraction. This was addressed by optimizing the NaOH concentration and incubation time to balance yield with the simplicity of the method.
Another challenge was ensuring that the extracted DNA was compatible with LAMP assays despite the presence of non-target tissue components, which required careful testing of assay conditions and verification of DNA integrity.
What limitations do you anticipate with the ColdSHOT method in clinical use?
ColdSHOT’s efficiency might be affected by temperature variations, as DNA extraction at ambient temperatures might differ in hotter or cooler climates. Additionally, the method may not fully digest larger tissue samples, potentially limiting its use to small biopsies. Sample stability in different storage conditions also poses a challenge, requiring further validation to ensure DNA integrity if samples cannot be processed immediately or stored properly.
Do you plan to adapt this method for other tissue samples or diagnostic purposes?
Though this study focused on skin biopsies, ColdSHOT could potentially be adapted for other small tissue types, especially where sample size is a constraint, such as needle biopsies or fine needle aspirates. Adapting ColdSHOT for different tissue types would require testing for DNA yield and compatibility with downstream assays like LAMP or PCR.
Future research could also explore ColdSHOT’s applicability in diagnosing other infectious diseases or conditions that require rapid DNA analysis at the POC.
How do you see POC diagnostics evolving in the next 5–10 years?
POC diagnostics are likely to become more integrated with digital health tools, enabling real-time data sharing and analysis. In oncology, advancements in molecular diagnostics, including isothermal amplification techniques like LAMP, could make it easier to monitor cancer biomarkers directly at the bedside.
Additionally, improvements in microfluidics and portable sequencing technology could further simplify complex diagnostic processes, bringing precision oncology closer to patients even in remote settings.
POC technologies will likely become more user-friendly and automated, reducing the need for highly trained personnel. Integration with mobile devices for data analysis and cloud-based storage could enable rapid feedback loops between patients and healthcare providers.
To maximize their potential, investment in robust supply chains, reliable power sources, and training programs for local healthcare workers will be crucial. Collaboration between researchers, industry, and public health organizations will also play a key role in scaling up these technologies to meet diverse clinical needs.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
References
- JC Manning et al., Sci Rep, 14 (2024). PMID: 38877073.